QT Vascular wins US appeal against US$20m award
Add BT as a preferred source
Angela Tan
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
AN APPEAL court in the US has reversed a district court ruling for Singapore-listed QT Vascular to pay more than US$20 million in damages to rival AngioScore Inc.
The protracted patent infringement battle tracing back to 2012 involved angioplasty balloons used to widen obstructed blood vessels.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar
